TapewireFind a company

person · Reporting owner

BARABE TIMOTHY C

Disclosed activity across 5 companies

Tapewire entity
28773
SEC CIK
0001237409

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Acer Therapeutics Inc.OPXA · Entity 108116DirectorNovember 18, 2016November 22, 2016
Cartesian Therapeutics, Inc.RNAC · Entity 6015DirectorJanuary 02, 2026January 06, 2026
Heartflow, Inc.HTFL · Entity 3993DirectorJuly 22, 2026July 24, 2026
VEEVA SYSTEMS INCVEEV · Entity 2124DirectorJune 22, 2021June 23, 2021

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Acer Therapeutics Inc.

Report date November 18, 2016 · Filed November 22, 2016

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect12,910 Ending reported balance After 2016-11-18 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2016-11-18 · Sale · Disposed 7,105 · Balance 20,719

Row 2 · 2016-11-18 · Sale · Disposed 7,809 · Balance 12,910

Warrants (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.00 · Expires 2018-04-08Direct0 Reported balance After 2016-11-18 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2016-11-18 · Sale · Disposed 16,000 · Balance 0

Cartesian Therapeutics, Inc.

Report date January 02, 2026 · Filed January 06, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect56,966 Reported balance After 2026-01-02 transaction · row 1
1 source row

Row 1 · 2026-01-02 · Grant · Acquired 2,600 · Balance 56,966

F1: Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest in full on January 2, 2027.

Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.76 · Expires 2036-01-01Direct7,800 Reported balance After 2026-01-02 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2026-01-02 · Grant · Acquired 7,800 · Balance 7,800

Filing footnotes · ownership attribution and instrument terms

F1: Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest in full on January 2, 2027.

Heartflow, Inc.

Report date July 22, 2026 · Filed July 24, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect188,231 Reported balance After 2026-07-22 transaction · row 1
1 source row

Row 1 · 2026-07-22 · Exercise / conversion · Acquired 3,710 · Balance 188,231

Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $19.00 · Expires 2035-08-07Direct15,000 Reported balance After 2026-07-22 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2026-07-22 · Exercise / conversion · Disposed 3,710 · Balance 15,000

F1: These stock options are fully exercisable.

Filing footnotes · ownership attribution and instrument terms

F1: These stock options are fully exercisable.

VEEVA SYSTEMS INC

Report date June 22, 2021 · Filed June 23, 2021

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Class A Common StockSEC Table I · non-derivativeDirect6,643 Reported balance After 2021-06-22 transaction · row 1
1 source row

Row 1 · 2021-06-22 · Exercise / conversion · Acquired 251 · Balance 6,643

F1: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act.

F2: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer.

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect0 Reported balance After 2021-06-22 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2021-06-22 · Exercise / conversion · Disposed 251 · Balance 0

F2: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer.

F1: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act.

F3: On June 25, 2020, the Reporting Person was granted 1,003 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 25, 2020, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act.

F2: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer.

F3: On June 25, 2020, the Reporting Person was granted 1,003 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 25, 2020, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

ARQULE INC

Report date January 16, 2020 · Filed January 16, 2020

Section 16 reporting ended · disclosed 2020-01-16. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect0 Reported balance After 2020-01-16 transaction · row 1
1 source row

Row 1 · 2020-01-16 · Other · Disposed 146,897 · Balance 0

F1: On December 6, 2019, ArQule, Inc. (the "Company") entered into an Agreement and Plan of Merger (as amended, supplemented or otherwise modified from time to time, the "Merger Agreement") with Merck Sharpe & Dohme Corp. ("MSD") and Argon Merger Sub, Inc., a wholly-owned subsidiary of MSD ("Merger Sub"), pursuant to which MSD acquired the Company by a tender offer for all shares of Company common stock (the "Offer") and a subsequent merger (the "Merger"), each of which became effective on January 16, 2020. Pursuant to the Merger Agreement, (i) Merger Sub purchased all shares of Company common stock that were validly tendered pursuant to the Offer for a cash payment equal to $20.00 per share (the "Offer Price") and (ii) all shares of Company common stock outstanding immediately prior to the effective time of the Merger (the "Effective Time"), were cancelled and converted automatically into the right to receive the Offer Price.

Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.48 · Expires 2028-05-08Direct0 Reported balance After 2020-01-16 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2020-01-16 · Disposition to issuer · Disposed 20,000 · Balance 0

F2: Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration.

Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.21 · Expires 2029-05-13Direct0 Reported balance After 2020-01-16 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2020-01-16 · Disposition to issuer · Disposed 40,000 · Balance 0

F2: Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration.

Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.14 · Expires 2020-05-13Direct0 Reported balance After 2020-01-16 transaction · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · 2020-01-16 · Disposition to issuer · Disposed 15,000 · Balance 0

F2: Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration.

Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.71 · Expires 2021-06-01Direct0 Reported balance After 2020-01-16 transaction · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · 2020-01-16 · Disposition to issuer · Disposed 15,000 · Balance 0

F2: Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration.

Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.82 · Expires 2022-05-24Direct0 Reported balance After 2020-01-16 transaction · row 6 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 6 · 2020-01-16 · Disposition to issuer · Disposed 15,000 · Balance 0

F2: Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration.

Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.78 · Expires 2023-05-20Direct0 Reported balance After 2020-01-16 transaction · row 7 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 7 · 2020-01-16 · Disposition to issuer · Disposed 15,000 · Balance 0

F2: Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration.

Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.42 · Expires 2024-05-13Direct0 Reported balance After 2020-01-16 transaction · row 8 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 8 · 2020-01-16 · Disposition to issuer · Disposed 15,000 · Balance 0

F2: Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration.

Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.80 · Expires 2025-05-11Direct0 Reported balance After 2020-01-16 transaction · row 9 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 9 · 2020-01-16 · Disposition to issuer · Disposed 15,000 · Balance 0

F2: Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration.

Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.68 · Expires 2026-05-24Direct0 Reported balance After 2020-01-16 transaction · row 10 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 10 · 2020-01-16 · Disposition to issuer · Disposed 20,000 · Balance 0

F2: Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration.

Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.23 · Expires 2027-05-23Direct0 Reported balance After 2020-01-16 transaction · row 11 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 11 · 2020-01-16 · Disposition to issuer · Disposed 20,000 · Balance 0

F2: Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration.

Filing footnotes · ownership attribution and instrument terms

F1: On December 6, 2019, ArQule, Inc. (the "Company") entered into an Agreement and Plan of Merger (as amended, supplemented or otherwise modified from time to time, the "Merger Agreement") with Merck Sharpe & Dohme Corp. ("MSD") and Argon Merger Sub, Inc., a wholly-owned subsidiary of MSD ("Merger Sub"), pursuant to which MSD acquired the Company by a tender offer for all shares of Company common stock (the "Offer") and a subsequent merger (the "Merger"), each of which became effective on January 16, 2020. Pursuant to the Merger Agreement, (i) Merger Sub purchased all shares of Company common stock that were validly tendered pursuant to the Offer for a cash payment equal to $20.00 per share (the "Offer Price") and (ii) all shares of Company common stock outstanding immediately prior to the effective time of the Merger (the "Effective Time"), were cancelled and converted automatically into the right to receive the Offer Price.

F2: Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 22, 2020 Filed Jun 24, 2020 20:45 UTC VEEVA SYSTEMS INC VEEV · Entity 2124 SaleClass A Common Stock 1,428 $238.45 $340,509.31
Disclosure

SEC source: 0001209191-20-038739 · doc4.xml · nonDerivative · entry 1

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,231

F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $238.4000 to $238.4558 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 20, 2020 Filed Jun 22, 2020 21:31 UTC VEEVA SYSTEMS INC VEEV · Entity 2124 Exercise / conversionRestricted Stock Units · Derivative 347 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-038245 · doc4.xml · derivative · entry 2

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 347 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer.

F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act.

F3 · derivative.exercise_date: On June 20, 2019, the Reporting Person was granted 1,387 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 20, 2019, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date.

F3 · derivative.expiration_date: On June 20, 2019, the Reporting Person was granted 1,387 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 20, 2019, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date.

Read SEC document
June 20, 2020 Filed Jun 22, 2020 21:31 UTC VEEVA SYSTEMS INC VEEV · Entity 2124 Exercise / conversionClass A Common Stock 347 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-038245 · doc4.xml · nonDerivative · entry 1

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,659

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act.

F2 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer.

Read SEC document
June 19, 2020 Filed Jun 23, 2020 23:54 UTC Cartesian Therapeutics, Inc. SELB · Entity 6015 GrantStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $3.00 $0.00
Disclosure

SEC source: 0001453687-20-000082 · wf-form4_159295647688923.xml · derivative · entry 1

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2030-06-18

F1 · derivative.exercise_date: The option vests in full on the earlier of June 19, 2021 or the day immediately prior to the company's 2021 annual meeting of stockholders.

Read SEC document
April 08, 2020 Filed Apr 9, 2020 21:49 UTC VEEVA SYSTEMS INC VEEV · Entity 2124 SaleClass A Common Stock 347 $156.00 $54,132.00
Disclosure

SEC source: 0001209191-20-024070 · doc4.xml · nonDerivative · entry 1

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,312

Read SEC document
March 20, 2020 Filed Mar 23, 2020 22:47 UTC VEEVA SYSTEMS INC VEEV · Entity 2124 Exercise / conversionRestricted Stock Units · Derivative 346 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-020720 · doc4.xml · derivative · entry 2

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 347

Underlying: Class A Common Stock · 346 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer.

F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act.

F3 · derivative.exercise_date: On June 20, 2019, the Reporting Person was granted 1,387 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 20, 2019, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date.

F3 · derivative.expiration_date: On June 20, 2019, the Reporting Person was granted 1,387 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 20, 2019, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date.

Read SEC document
March 20, 2020 Filed Mar 23, 2020 22:47 UTC VEEVA SYSTEMS INC VEEV · Entity 2124 Exercise / conversionClass A Common Stock 346 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-020720 · doc4.xml · nonDerivative · entry 1

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,659

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act.

F2 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer.

Read SEC document
March 17, 2020 Filed Mar 19, 2020 21:16 UTC Cartesian Therapeutics, Inc. SELB · Entity 6015 PurchaseCommon Stock 5,000 $2.00 $10,000.00
Disclosure

SEC source: 0001453687-20-000030 · wf-form4_158465256831834.xml · nonDerivative · entry 1

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 88,173

Read SEC document
January 16, 2020 Filed Jan 16, 2020 15:58 UTC ARQULE INC ARQL · Entity 11927 Disposition to issuerStock Option (Right to Buy) · Derivative 20,000 Not disclosed Strike: $1.23 Not disclosed
Disclosure

SEC source: 0001104659-20-004730 · tm203607d11_4.xml · derivative · entry 11

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires 2027-05-23

F2 · price: Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration.

F2 · derivative.exercise_date: Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration.

Read SEC document
January 16, 2020 Filed Jan 16, 2020 15:58 UTC ARQULE INC ARQL · Entity 11927 Disposition to issuerStock Option (Right to Buy) · Derivative 20,000 Not disclosed Strike: $1.68 Not disclosed
Disclosure

SEC source: 0001104659-20-004730 · tm203607d11_4.xml · derivative · entry 10

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires 2026-05-24

F2 · price: Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration.

F2 · derivative.exercise_date: Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration.

Read SEC document
January 16, 2020 Filed Jan 16, 2020 15:58 UTC ARQULE INC ARQL · Entity 11927 Disposition to issuerStock Option (Right to Buy) · Derivative 15,000 Not disclosed Strike: $1.80 Not disclosed
Disclosure

SEC source: 0001104659-20-004730 · tm203607d11_4.xml · derivative · entry 9

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,000 shares

Expires 2025-05-11

F2 · price: Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration.

F2 · derivative.exercise_date: Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration.

Read SEC document
January 16, 2020 Filed Jan 16, 2020 15:58 UTC ARQULE INC ARQL · Entity 11927 Disposition to issuerStock Option (Right to Buy) · Derivative 15,000 Not disclosed Strike: $1.42 Not disclosed
Disclosure

SEC source: 0001104659-20-004730 · tm203607d11_4.xml · derivative · entry 8

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,000 shares

Expires 2024-05-13

F2 · price: Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration.

F2 · derivative.exercise_date: Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration.

Read SEC document
January 16, 2020 Filed Jan 16, 2020 15:58 UTC ARQULE INC ARQL · Entity 11927 Disposition to issuerStock Option (Right to Buy) · Derivative 15,000 Not disclosed Strike: $2.78 Not disclosed
Disclosure

SEC source: 0001104659-20-004730 · tm203607d11_4.xml · derivative · entry 7

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,000 shares

Expires 2023-05-20

F2 · price: Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration.

F2 · derivative.exercise_date: Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration.

Read SEC document
January 16, 2020 Filed Jan 16, 2020 15:58 UTC ARQULE INC ARQL · Entity 11927 Disposition to issuerStock Option (Right to Buy) · Derivative 15,000 Not disclosed Strike: $5.82 Not disclosed
Disclosure

SEC source: 0001104659-20-004730 · tm203607d11_4.xml · derivative · entry 6

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,000 shares

Expires 2022-05-24

F2 · price: Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration.

F2 · derivative.exercise_date: Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration.

Read SEC document
January 16, 2020 Filed Jan 16, 2020 15:58 UTC ARQULE INC ARQL · Entity 11927 Disposition to issuerStock Option (Right to Buy) · Derivative 15,000 Not disclosed Strike: $6.71 Not disclosed
Disclosure

SEC source: 0001104659-20-004730 · tm203607d11_4.xml · derivative · entry 5

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,000 shares

Expires 2021-06-01

F2 · price: Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration.

F2 · derivative.exercise_date: Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration.

Read SEC document
January 16, 2020 Filed Jan 16, 2020 15:58 UTC ARQULE INC ARQL · Entity 11927 Disposition to issuerStock Option (Right to Buy) · Derivative 15,000 Not disclosed Strike: $6.14 Not disclosed
Disclosure

SEC source: 0001104659-20-004730 · tm203607d11_4.xml · derivative · entry 4

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,000 shares

Expires 2020-05-13

F2 · price: Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration.

F2 · derivative.exercise_date: Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration.

Read SEC document
January 16, 2020 Filed Jan 16, 2020 15:58 UTC ARQULE INC ARQL · Entity 11927 Disposition to issuerStock Option (Right to Buy) · Derivative 40,000 Not disclosed Strike: $6.21 Not disclosed
Disclosure

SEC source: 0001104659-20-004730 · tm203607d11_4.xml · derivative · entry 3

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 40,000 shares

Expires 2029-05-13

F2 · price: Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration.

F2 · derivative.exercise_date: Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration.

Read SEC document
January 16, 2020 Filed Jan 16, 2020 15:58 UTC ARQULE INC ARQL · Entity 11927 Disposition to issuerStock Option (Right to Buy) · Derivative 20,000 Not disclosed Strike: $2.48 Not disclosed
Disclosure

SEC source: 0001104659-20-004730 · tm203607d11_4.xml · derivative · entry 2

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,000 shares

Expires 2028-05-08

F2 · price: Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration.

F2 · derivative.exercise_date: Pursuant to the Merger Agreement, immediately prior to the Effective Time, all outstanding Company stock options, to the extent unvested, became fully vested, and at the Effective Time, each outstanding Company stock option was cancelled and converted into the right to receive an amount of cash (subject to any applicable withholding or other taxes required by applicable law) determined by multiplying (i) the number of shares of Company common stock subject to such stock option immediately prior to such cancellation by (ii) the excess, if any, of an amount in cash equal to the Offer Price, without any interest, over the exercise price per share of Company common sotck subject to such stock option, less any applicable tax withholding. Any such option that had an exercise price that equaled or exceeded the Offer Price was cancelled for no consideration.

Read SEC document
January 16, 2020 Filed Jan 16, 2020 15:58 UTC ARQULE INC ARQL · Entity 11927 OtherCommon Stock 146,897 $20.00 $2,937,940.00
Disclosure

SEC source: 0001104659-20-004730 · tm203607d11_4.xml · nonDerivative · entry 1

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: On December 6, 2019, ArQule, Inc. (the "Company") entered into an Agreement and Plan of Merger (as amended, supplemented or otherwise modified from time to time, the "Merger Agreement") with Merck Sharpe & Dohme Corp. ("MSD") and Argon Merger Sub, Inc., a wholly-owned subsidiary of MSD ("Merger Sub"), pursuant to which MSD acquired the Company by a tender offer for all shares of Company common stock (the "Offer") and a subsequent merger (the "Merger"), each of which became effective on January 16, 2020. Pursuant to the Merger Agreement, (i) Merger Sub purchased all shares of Company common stock that were validly tendered pursuant to the Offer for a cash payment equal to $20.00 per share (the "Offer Price") and (ii) all shares of Company common stock outstanding immediately prior to the effective time of the Merger (the "Effective Time"), were cancelled and converted automatically into the right to receive the Offer Price.

Read SEC document
December 23, 2019 Filed Dec 26, 2019 22:30 UTC Cartesian Therapeutics, Inc. SELB · Entity 6015 GrantWarrants · Derivative 32,840 $0.13 Strike: $1.46 $4,105.00
Disclosure

SEC source: 0001104659-19-076223 · a4.xml · derivative · entry 2

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,840

Underlying: Common Stock · 32,840 shares

Expires 2024-12-23

Read SEC document
December 23, 2019 Filed Dec 26, 2019 22:30 UTC Cartesian Therapeutics, Inc. SELB · Entity 6015 GrantCommon Stock 65,681 $1.46 $95,894.26
Disclosure

SEC source: 0001104659-19-076223 · a4.xml · nonDerivative · entry 1

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,173

Read SEC document
December 20, 2019 Filed Dec 20, 2019 22:40 UTC VEEVA SYSTEMS INC VEEV · Entity 2124 Exercise / conversionRestricted Stock Units · Derivative 347 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-061622 · doc4.xml · derivative · entry 2

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 693

Underlying: Class A Common Stock · 347 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer.

F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act.

F3 · derivative.exercise_date: On June 20, 2019, the Reporting Person was granted 1,387 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 20, 2019, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date.

F3 · derivative.expiration_date: On June 20, 2019, the Reporting Person was granted 1,387 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 20, 2019, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date.

Read SEC document
December 20, 2019 Filed Dec 20, 2019 22:40 UTC VEEVA SYSTEMS INC VEEV · Entity 2124 Exercise / conversionClass A Common Stock 347 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-061622 · doc4.xml · nonDerivative · entry 1

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,313

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act.

F2 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer.

Read SEC document
September 20, 2019 Filed Sep 23, 2019 20:12 UTC VEEVA SYSTEMS INC VEEV · Entity 2124 Exercise / conversionRestricted Stock Units · Derivative 347 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-050446 · doc4.xml · derivative · entry 2

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,040

Underlying: Class A Common Stock · 347 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer.

F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act.

F3 · derivative.exercise_date: On June 20, 2019, the Reporting Person was granted 1,387 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 20, 2019, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date.

F3 · derivative.expiration_date: On June 20, 2019, the Reporting Person was granted 1,387 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 20, 2019, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date.

Read SEC document
September 20, 2019 Filed Sep 23, 2019 20:12 UTC VEEVA SYSTEMS INC VEEV · Entity 2124 Exercise / conversionClass A Common Stock 347 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-050446 · doc4.xml · nonDerivative · entry 1

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,966

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act.

F2 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer.

Read SEC document
August 13, 2019 Filed Aug 15, 2019 20:19 UTC Cartesian Therapeutics, Inc. SELB · Entity 6015 PurchaseCommon Stock 10,000 $1.72 $17,200.00
Disclosure

SEC source: 0001453687-19-000106 · wf-form4_156590036429438.xml · nonDerivative · entry 1

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,492

Read SEC document
June 20, 2019 Filed Jun 21, 2019 22:20 UTC VEEVA SYSTEMS INC VEEV · Entity 2124 GrantRestricted Stock Units · Derivative 1,387 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-038623 · doc4.xml · derivative · entry 1

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,387

Underlying: Class A Common Stock · 1,387 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer.

F2 · derivative.exercise_date: The RSUs were granted under the Issuer's 2013 Equity Incentive Plan. The Reporting Person vests ownership in the RSUs over one year, with 1/4 of the RSUs vesting on September 20, 2019, and the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service by the Reporting Person to the Issuer.

F2 · derivative.expiration_date: The RSUs were granted under the Issuer's 2013 Equity Incentive Plan. The Reporting Person vests ownership in the RSUs over one year, with 1/4 of the RSUs vesting on September 20, 2019, and the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service by the Reporting Person to the Issuer.

Read SEC document
June 18, 2019 Filed Jun 19, 2019 20:07 UTC VEEVA SYSTEMS INC VEEV · Entity 2124 SaleClass A Common Stock 727 $167.19 $121,549.38
Disclosure

SEC source: 0001209191-19-037988 · doc4.xml · nonDerivative · entry 1

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,619

F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $167.1875 to $167.2052 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 14, 2019 Filed Jun 18, 2019 20:20 UTC Cartesian Therapeutics, Inc. SELB · Entity 6015 GrantStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $2.10 $0.00
Disclosure

SEC source: 0001453687-19-000069 · wf-form4_156088923042633.xml · derivative · entry 1

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2029-06-13

F1 · derivative.exercise_date: The option vests in full on the earlier of June 14, 2020 or the day immediately prior to the company's 2020 annual meeting of stockholders.

Read SEC document
June 13, 2019 Filed Jun 17, 2019 20:07 UTC VEEVA SYSTEMS INC VEEV · Entity 2124 Exercise / conversionRestricted Stock Units · Derivative 727 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-037376 · doc4.xml · derivative · entry 2

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 727 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer.

F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act.

F3 · derivative.exercise_date: On June 13, 2018, the Reporting Person was granted 2,908 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 13, 2018, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date.

F3 · derivative.expiration_date: On June 13, 2018, the Reporting Person was granted 2,908 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 13, 2018, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date.

Read SEC document
June 13, 2019 Filed Jun 17, 2019 20:07 UTC VEEVA SYSTEMS INC VEEV · Entity 2124 Exercise / conversionClass A Common Stock 727 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-037376 · doc4.xml · nonDerivative · entry 1

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,346

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act.

F2 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer.

Read SEC document
May 14, 2019 Filed May 15, 2019 12:12 UTC ARQULE INC ARQL · Entity 11927 GrantDirector Stock Options · Derivative 40,000 $0.00 Strike: $6.21 $0.00
Disclosure

SEC source: 0001019695-19-000018 · primary_doc.xml · derivative · entry 1

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2029-05-13

F1 · derivative.exercise_date: The options vest 1 year from date of grant.

Read SEC document
April 04, 2019 Filed Apr 8, 2019 16:17 UTC ARQULE INC ARQL · Entity 11927 Exercise / conversionDirector Stock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $3.87 $0.00
Disclosure

SEC source: 0001019695-19-000010 · primary_doc.xml · derivative · entry 2

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2019-05-14

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Fully vested.

Read SEC document
April 04, 2019 Filed Apr 8, 2019 16:17 UTC ARQULE INC ARQL · Entity 11927 Exercise / conversionCommon Stock 10,000 $3.87 $38,700.00
Disclosure

SEC source: 0001019695-19-000010 · primary_doc.xml · nonDerivative · entry 1

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 146,897

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Reflects the exercise of 10,000 shares that were subject to an option. All exercised shares were retained by Mr. Timothy C. Barabe and no shares were sold.

Read SEC document
April 02, 2019 Filed Apr 3, 2019 21:28 UTC VEEVA SYSTEMS INC VEEV · Entity 2124 SaleClass A Common Stock 727 $127.41 $92,623.44
Disclosure

SEC source: 0001209191-19-023340 · doc4.xml · nonDerivative · entry 1

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,619

Read SEC document
March 13, 2019 Filed Mar 15, 2019 20:18 UTC VEEVA SYSTEMS INC VEEV · Entity 2124 Exercise / conversionRestricted Stock Units · Derivative 727 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-019687 · doc4.xml · derivative · entry 2

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 727

Underlying: Class A Common Stock · 727 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer.

F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act.

F3 · derivative.exercise_date: On June 13, 2018, the Reporting Person was granted 2,908 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 13, 2018, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date.

F3 · derivative.expiration_date: On June 13, 2018, the Reporting Person was granted 2,908 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 13, 2018, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date.

Read SEC document
March 13, 2019 Filed Mar 15, 2019 20:18 UTC VEEVA SYSTEMS INC VEEV · Entity 2124 Exercise / conversionClass A Common Stock 727 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-019687 · doc4.xml · nonDerivative · entry 1

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,346

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act.

F2 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer.

Read SEC document
December 13, 2018 Filed Dec 15, 2018 00:28 UTC VEEVA SYSTEMS INC VEEV · Entity 2124 Exercise / conversionRestricted Stock Units · Derivative 727 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-062822 · doc4.xml · derivative · entry 2

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,454

Underlying: Class A Common Stock · 727 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer.

F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act.

F3 · derivative.exercise_date: On June 13, 2018, the Reporting Person was granted 2,908 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 13, 2018, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date.

F3 · derivative.expiration_date: On June 13, 2018, the Reporting Person was granted 2,908 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 13, 2018, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date.

Read SEC document
December 13, 2018 Filed Dec 15, 2018 00:28 UTC VEEVA SYSTEMS INC VEEV · Entity 2124 Exercise / conversionClass A Common Stock 727 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-062822 · doc4.xml · nonDerivative · entry 1

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,619

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act.

F2 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer.

Read SEC document
September 27, 2018 Filed Sep 28, 2018 20:42 UTC VEEVA SYSTEMS INC VEEV · Entity 2124 SaleClass A Common Stock 727 $105.00 $76,335.00
Disclosure

SEC source: 0001209191-18-052566 · doc4.xml · nonDerivative · entry 1

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,892

Read SEC document
September 13, 2018 Filed Sep 14, 2018 20:06 UTC VEEVA SYSTEMS INC VEEV · Entity 2124 Exercise / conversionRestricted Stock Units · Derivative 727 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-051047 · doc4.xml · derivative · entry 2

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,181

Underlying: Class A Common Stock · 727 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer.

F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act.

F3 · derivative.exercise_date: On June 13, 2018, the Reporting Person was granted 2,908 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 13, 2018, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date.

F3 · derivative.expiration_date: On June 13, 2018, the Reporting Person was granted 2,908 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 13, 2018, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date.

Read SEC document
September 13, 2018 Filed Sep 14, 2018 20:06 UTC VEEVA SYSTEMS INC VEEV · Entity 2124 Exercise / conversionClass A Common Stock 727 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-051047 · doc4.xml · nonDerivative · entry 1

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,619

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act.

F2 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer.

Read SEC document
June 21, 2018 Filed Jun 22, 2018 21:48 UTC VEEVA SYSTEMS INC VEEV · Entity 2124 Exercise / conversionRestricted Stock Units · Derivative 701 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-039295 · doc4.xml · derivative · entry 2

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 701 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer.

F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act.

F3 · derivative.exercise_date: On June 21, 2017, the Reporting Person was granted 2,804 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 21, 2017, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date.

F3 · derivative.expiration_date: On June 21, 2017, the Reporting Person was granted 2,804 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 21, 2017, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date.

Read SEC document
June 21, 2018 Filed Jun 22, 2018 21:48 UTC VEEVA SYSTEMS INC VEEV · Entity 2124 Exercise / conversionClass A Common Stock 701 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-039295 · doc4.xml · nonDerivative · entry 1

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,892

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act.

F2 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer.

Read SEC document
June 15, 2018 Filed Jun 19, 2018 23:04 UTC Cartesian Therapeutics, Inc. SELB · Entity 6015 GrantStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $12.75 $0.00
Disclosure

SEC source: 0001638599-18-000675 · doc4_5482.xml · derivative · entry 1

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2028-06-14

F1 · derivative.exercise_date: The option vests in full on the earlier of June 15, 2019 or the day immediately prior to the company's 2019 annual meeting of shareholders.

Read SEC document
June 13, 2018 Filed Jun 15, 2018 21:08 UTC VEEVA SYSTEMS INC VEEV · Entity 2124 GrantRestricted Stock Units · Derivative 2,908 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-038111 · doc4.xml · derivative · entry 1

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,908

Underlying: Class A Common Stock · 2,908 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer.

F2 · derivative.exercise_date: The RSUs were granted under the Issuer's 2013 Equity Incentive Plan. The Reporting Person vests ownership in the RSUs over one year, with 1/4 of the RSUs vesting on September 13, 2018, and the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service by the Reporting Person to the Issuer.

F2 · derivative.expiration_date: The RSUs were granted under the Issuer's 2013 Equity Incentive Plan. The Reporting Person vests ownership in the RSUs over one year, with 1/4 of the RSUs vesting on September 13, 2018, and the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service by the Reporting Person to the Issuer.

Read SEC document
May 31, 2018 Filed Jun 4, 2018 21:46 UTC VEEVA SYSTEMS INC VEEV · Entity 2124 SaleClass A Common Stock 701 $77.54 $54,355.54
Disclosure

SEC source: 0001209191-18-035266 · doc4.xml · nonDerivative · entry 1

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,191

Read SEC document
May 08, 2018 Filed May 10, 2018 12:09 UTC ARQULE INC ARQL · Entity 11927 GrantDirector Stock Options · Derivative 20,000 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0001019695-18-000001 · primary_doc.xml · derivative · entry 1

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2028-05-08

F1 · derivative.exercise_date: The options vest 1 year from the date of grant May 8, 2018.

Read SEC document
March 21, 2018 Filed Mar 23, 2018 20:43 UTC VEEVA SYSTEMS INC VEEV · Entity 2124 Exercise / conversionRestricted Stock Units · Derivative 701 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-021414 · doc4.xml · derivative · entry 2

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 701

Underlying: Class A Common Stock · 701 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer.

F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act.

F3 · derivative.exercise_date: On June 21, 2017, the Reporting Person was granted 2,804 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 21, 2017, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date.

F3 · derivative.expiration_date: On June 21, 2017, the Reporting Person was granted 2,804 RSUs under the Issuer's 2013 Equity Incentive Plan, of which 1/4 of the RSUs vested on September 21, 2017, with the remaining RSUs vesting equally on a quarterly basis thereafter, subject to continued service on the Issuer's board of directors on the applicable vesting date.

Read SEC document
March 21, 2018 Filed Mar 23, 2018 20:43 UTC VEEVA SYSTEMS INC VEEV · Entity 2124 Exercise / conversionClass A Common Stock 701 $0.00 $0.00
Disclosure

SEC source: 0001209191-18-021414 · doc4.xml · nonDerivative · entry 1

BARABE TIMOTHY C · CIK 0001237409 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,892

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Transaction exempt from Section 16(b) of the Securities Exchange Act of 1934 (the "Act") pursuant to Rule 16b-6(b) promulgated under the Act.

F2 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Class A Common Stock of the Issuer.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.